Product Description
A convenient set consisting of eight Receptor Tyrosine Kinase (RTK) inhibitors. The eight inhibitors are: 5 mg of Axitinib (Cat. No. 1581-5), 5 mg of Canertinib (Cat. No. 1617-5), 5 mg of Gefitinib (Cat. No. 1589-5), 5 mg of GW2580 (Cat. No. 1740-5), 25 mg of Lapatinib Ditosylate (Cat. No. 1624-25), 1 mg of PD-173074 (Cat. No. 1675-1), 1 mg of SB-431542 (Cat. No. 1674-1), and 100 mg of Sunitinib Malate (Cat. No. 1611-100).
DiscoveryPak™ Receptor Tyrosine Kinase (RTK) Inhibitor Set is a convenient set consisting of eight Receptor Tyrosine Kinase (RTK) inhibitors. The eight inhibitors are: 5 mg of Axitinib (Cat. No. 1581-5), 5 mg of Canertinib (Cat. No. 1617-5), 5 mg of Gefitinib (Cat. No. 1589-5), 5 mg of GW2580 (Cat. No. 1740-5), 25 mg of Lapatinib Ditosylate (Cat. No. 1624-25), 1 mg of PD-173074 (Cat. No. 1675-1), 1 mg of SB-431542 (Cat. No. 1674-1), and 100 mg of Sunitinib Malate (Cat. No. 1611-100).
Biovision | K859 | DiscoveryPak™ Receptor Tyrosine Kinase (RTK) Inhibitor Set DataSheet
Alternate Name/Synonyms: Receptor Tyrosine Kinase (RTK) Inhibitor Set, DiscoveryPak™
Appearance: Lyophilized solids
Formulation: N/A
CAS Number: See under the individual product
Structure Available?: See under the individual product
Peptide sequence: N/A
Salt Form: No
Molecular Formula: See under the individual product
Molecular Weight: See under the individual product
Cell-Permeable?: Yes
Purity: ≥95% by HPLC
Solubilities: DMSO
Handling: Protect from air, light and moisture
Country of Origin: USA
Tag Line: A Receptor Tyrosine Kinase (RTK) inhibitors panel
MDL Number: N/A
PubChem CID: N/A
SMILES: N/A
InChi: N/A
InChi Key: N/A